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Aim: To identify a suite of the key physical, emotional and social outcomes to be employed in 
clinical practice and research concerning Perthes' disease in children.  
Methods: The study follows the guidelines of the COMET-Initiative (Core Outcome Measures 
in Effectiveness Trials). A systematic review of the literature was performed to identify a list 
of outcomes reported in previous studies. Additional outcomes were sought, interviewing 12 
children affected by Perthes’ disease and 18 related parents, using a semi-structured interview 
format. Collectively, these outcomes formed the basis of a Delphi survey (2 rounds), where 18 
patients with Perthes’ disease, 46 parents and 36 orthopaedic surgeons rated each outcome for 
importance. The International Perthes Study Group (IPSG) (Dallas, Tx – October 2018) 
discussed outcomes that failed to reach any consensus (either ‘in’ or ‘out’) before a final 
consensus meeting with representatives of surgeons, patients and parents. 
Results: 23 different outcome domains were identified from the systematic review, and a 
further 10 from qualitative interviews. After round 1 of the Delphi survey, participants 
suggested 5 further outcomes domains. A total of 38 outcomes were scored in round 2 of the 
Delphi. Among these, 16 outcomes were scored over the pre-specified 70% threshold for 
importance (divided in 6 main categories: adverse events; life impact; resource use; 
pathophysiological manifestations; death; technical considerations). Following the final 
consensus meeting, 14 outcomes were included in the final Core Outcomes Set (COS). 
Conclusion: COSs are important to improve standardization of outcomes in clinical research 
and to aid communication between patients, clinicians and funding bodies. We hope that the 
results of this study will be a catalyst to develop high quality clinical research to determine the 
optimal treatments from children with Perthes’ disease. 
KEYWORDS: Core outcomes set; Delphi; Perthes’ disease; Legg-Calvé-Perthes’ disease 
INTRODUCTION 
Perthes’ disease (also known as Legg-Calvé-Perthes disease) is an idiopathic osteonecrosis of 
the femoral head in children [1, 2]. It is unclear what causes the disease, although socio-
economic deprivation has been demonstrated to be the primary risk factor [3, 4]. Perthes’ 
disease occurs five times more in boys than in girls, with a greatest incidence amongst white 
children in the UK and North Europe [2-5]. Symptoms of the disease include limping, stiffness 
of the hip joint and pain. Typical onset is between the ages of 4 and 8 years [1, 3].  
Clinical management of Perthes’ disease focuses on the prevention of the femoral head collapse 
and functional recovery (recovery of hip motion; reduction of pain) [6, 7]. Treatment 
approaches vary between surgical interventions (e.g. varus or shelf osteotomy) and non-
surgical interventions (e.g. bed rest or wheelchair), but importantly the management guidelines 
differ between countries, between hospitals and even among surgeons within the same hospital 
[8]. The debate on which treatment gives the best outcomes is ongoing, and divergent opinions 
on Perthes’ disease management in the paediatric orthopaedic community have been, in part, 
borne out through the absence of standardised outcomes [9].  
Core Outcomes Sets (COS) represent consensus-derived minimum sets of outcomes to be 
reported in studies investigating a specific condition [10, 11]. By establishing a minimum set 
of outcomes to record, this will enable comparisons to be made between studies, and facilitate 
meaningful meta-analyses [11].  The use of COS is well-established through clinical research, 
though their adoption is somewhat slower in orthopaedic surgery.  
The aim of our study was to identify, using the COMET-Initiative (Core Outcome Measures in 
Effectiveness Trials) guidelines, a suite of key physical, emotional and social outcomes to be 




We searched the Cochrane Library, PubMed and Web of Science databases to identify 
manuscripts related to the management of Perthes’ disease, with either operative or non-
operative interventions, between January 1990 and January 2017 using the search strategy 
outlined in the study protocol [9]. All randomised controlled studies, cohort studies and case 
series that included patients treated for Perthes’ disease, irrespective of their treatment type, 
that reported childhood outcomes of the disease, were included. Inclusion criteria were 
established following the PICO (Population Intervention Comparison Outcomes) approach: 1) 
Population: children with Perthes’ disease; 2) Intervention and 3) Comparator: any treatment; 
4) Outcomes: any outcome. Only manuscripts written in English language were included. 
Study eligibility was assessed by two independent reviewers (DGL and WYL) who screened 
all the titles and abstract using Rayyan software [12]. The full text article was obtained for all 
manuscripts fulfilling the inclusion criteria. Data from all eligible studies were extracted as 
detailed in the study protocol [9], which involved identification of the primary objective of the 
study, prospective/retrospective data collection, study type, population, number of patients, 
conservative management, surgical management, primary and secondary outcomes measured, 
outcomes assessment tools and follow-up. All outcomes obtained were categorised into 1 of 
the 5 domains of the OMERACT filter 2.0 [11], which includes the areas that should be covered 
by outcomes measures in order to ensure an adequate reporting of the results. Domains were 
divided in: 1) adverse event; 2) life impact; 3) resource use; 4) pathophysiological 
manifestations; and 5) death. A sixth domain of “technical consideration”, suggested by 
Dorman et al [13], not present in the original OMERACT filter, was also included. 
Qualitative Interviews 
Qualitative interviews were held with parents and children to identify the key outcomes of 
Perthes’ disease amongst families. The methods and in-depth outcomes are reported elsewhere 
[14]. 
Delphi Survey 
The list of outcomes obtained from the systematic review and qualitative interviews were 
combined in a Delphi Survey to identify the core outcomes important to key stakeholders. 
Stakeholders included orthopaedic surgeons, patients and parents with invites targeted to 
groups around the world. The Delphi Survey involved two stages (rounds), each lasting 3 
weeks. The first round of the survey collected participants’ demographic data (participant 
name, stakeholder group, country), and asked the participants to score the list of suggested 
outcomes (between a score of 1-9, where “1-3=not relevant”; “4-6=important but not critical”; 
“7-9=extremely relevant”). As part of the first round, participants were also given the 
opportunity to suggest additional important outcomes not otherwise identified. The data 
obtained from round 1 were then analysed using bar charts stratified by stakeholder group. A 
second survey (round 2) was then conducted presenting the graphical output of each outcome 
by stakeholder group, with additional outcomes also added. Participants were invited to score 
again these outcomes using the same descriptors and with the possibility to change their scores 
if they wished to. Data obtained from round 2 were then summarised using the GRADE 
guidelines[15] as “consensus in”, “consensus out” or “no consensus”. “Consensus In” was 
defined as the agreement of the vast majority (>70% of the group) on considering the outcome 
extremely relevant (7-9 points range), with only a minority (<15% of the group) considering 
the outcome not relevant (1-3 points range). “Consensus Out” was defined as the agreement of 
the vast majority (>70% of the group) on considering the outcome not relevant (1-3 points 
range), with only a minority (<15% of the group) considering the outcome extremely relevant 
(7-9 points range). 
International Involvement 
The summary of data from both rounds of the Delphi survey was presented to 20 international 
surgeons at the International Perthes Study Group (IPSG) meeting in Dallas in October 2018, 
to seek additional feedback from this expert group. Participants were given the opportunity to 
discuss the Delphi survey results and put forward any comments for discussion at the final 
consensus meeting. The only role of the IPSG was to give suggestions and guide the 
international representatives attending the final consensus meeting.  
Final Consensus meeting 
The list of outcomes obtained from the Delphi Survey was taken to a consensus meeting in 
January 2019. There were 10 participants: 3 international surgeon representatives; 3 
international parents/patients’ representatives; a physiotherapist; 2 of the researchers involved 
in the study; and an independent chair (who did not participate in the voting procedure). 
First, the full list of 38 outcomes included in the Delphi survey were presented, with outcomes 
split according to if they were “consensus in”; “consensus out”; or “no consensus”. There was 
the opportunity for open discussion related to all outcomes, with any comments from the IPSG 
made available to the group. Participants asked to anonymously score each outcome, using an 






709 papers were identified from preliminary database searches. After additional title and 
abstract screening, 552 papers were excluded which were not pertinent to Perthes’ disease; 
were duplicates; or which did not report outcomes following an intervention. Of the remaining 
157, we were unable to access the full text of 45 papers. Outcomes were sought from 112 
papers. Figure 1 shows the PRISMA flow diagram of the papers identification process. After 
data extraction 23 individual outcome domains were identified, and categorised according to 
the OMERACT modified filter domains (Table 1).  
 
Figure 1: Prisma flow diagram showing papers identification and inclusion process.  
 
Table 1: Systematic review outcomes categorised in domains (OMERACT modified filter). 
 
Patients Reported Outcomes 
10 outcomes not identified through the systematic review process were identified from 
qualitative interviews with parents [14] and added. The full list of the patient reported outcomes 
(PROs) obtained is reported in Table 2. 
 




Round 1 of the Delphi included a total of 162 participants, with 27% surgeons (n=44); 56% 
parents (n=91); and 17% affected individuals (n=27). The majority of participants were from 
the UK (49%, n=79) with significant representation from the USA (28%, n=46), and with a 
large spread of 12 other countries also represented (23%, n=37). In round 2, 62 participants 
(38% of round 1) did not respond to the second round of the survey despite prompts. The final 
number of participants’ in round 2 was 100, including 36 surgeons (36% of the total 
participants); 46 parents (46%), and 18 affected individuals (18%) (Figure 3). Attendance in 
round 2 involved equal participation from the UK and USA, with UK 40% (n=40) of the total 
participants, and USA 40% (n=40) of the total participants. The remaining 20% (n=20) of 
participants were from 12 other countries (Figure 3). The total participants’ attendance of round 
2 was 62% of round 1.   
Six additional outcomes were suggested after round 1 (Table 3) and included in round 2. Of 
the final 38 outcomes, 17 obtained “consensus in”, 22 obtained “no consensus”, and none 
obtained “consensus out” after round 2. Table 4 shows the final list of the 16 outcomes that 
reached “consensus in” after the two rounds of the Delphi survey.  
 
Figure 2: Participants’ distribution Delphi round 2. 
 
Figure 3: Round 2 Delphi survey participants’ demographic data. 
 
Table 3: Additional suggested outcomes after round 1 of the Delphi. 
 
Table 4: List of the outcomes that obtained “consensus in” after round 2 of the Delphi. 
 
 
IPSG Meeting Feedback 
During the IPSG meeting, outcomes that did not reach any consensus (i.e. failed to reach either 
consensus ‘in’ or consensus ‘out’) during the two rounds of the Delphi process were discussed. 
From this discussion, notes were taken to the final consensus meeting for further final 
adjudication. 
 
Final Consensus Meeting 
Domain “Life Impact” - Nine outcomes reached “consensus in” during the Delphi Survey. 
Considering the large number of outcomes proposed, the final consensus group felt that three 
(sit comfortably; walking distance; and limping) could be broadly encapsulated under the 
heading of “activities of daily living”. Sport participation did not reach any consensus, but was 
subsequently voted “in” as this was thought to add functional information beyond activities of 
“daily living”. Three outcomes were added by participants during round 1 of the Delphi (weight 
gain; ability to climb stairs; use of walking aids), though these did not reach any consensus, 
and were subsequently voted “out”. All other outcomes of the domain “Life Impact” that did 
not reach any consensus were voted “out” and excluded from the final COS.   
Domain “Adverse Events” - Two outcomes reached “consensus in” during the Delphi survey. 
Of these, “deformity” was voted “out” at the final consensus meeting because participants felt 
that this was captured through radiographic outcomes. The outcomes of this domain that did 
not reach any consensus during the Delphi were voted “out” of the final COS.  
Domain “Technical Considerations” - Four outcomes reached “consensus in” during the Delphi 
survey, and were voted “in” at the consensus meeting to be included in the final COS. The 
consensus group considered “Acetabular congruency” and “hip congruency”, and felt that these 
were best combined to form a single outcome domain. Two outcomes did not reach any 
consensus during the Delphi Survey but were suggested to warrant particular further discussion 
by IPSG (overgrowth of great trochanter; articulo-trochanteric distance) however, these were 
voted “out” by the consensus group and excluded from the final COS. Other outcomes were 
voted “out” of the final COS. 
Domain “Resource Use” - The outcome “requirement for further surgery” did not reach any 
consensus during the Delphi survey but was voted “in” by the consensus group, and was 
included in the final COS. Other outcomes were voted “out” of the final COS. 
Domain “Pathophysiological Manifestation” - “Hip mobility” did not reach any consensus 
during the Delphi Survey, and caused considerable debate on how this may be recorded. This 
was voted “in” by the consensus group, as it was felt that stiffness was a significant 
consideration in the progress of the disease. The documentation may be through formal 
measurement of  hip movement, or through self-reported documentation of a limp 
(acknowledging that other components other than purely hip mobility may contribute to a 
limp). Other outcomes were voted “out” of the final COS. 
In total 38 outcomes were presented to the consensus group and 14 outcomes were included in 
the final COS list (Table 5). 
 
Table 5: List of the outcomes that reached “consensus in” to be included in the COS 
 
DISCUSSION 
We have developed a COS based on an in depth analysis of the literature, together with 
qualitative input from children affected by Perthes’ disease, their parents and clinicians treating 
children with Perthes’ disease. The COS consists of 14 outcomes that are important to both 
patients and clinical professionals. We recommend that researchers ensure that they incorporate 
the COS when undertaking future high-quality clinical studies for Perthes’ disease. It should 
be emphasised that this is a minimum dataset, and investigators remain free to add additional 
measures. 
The relevance and use of COS has been already described across medicine [11, 17], propagated 
by the COMET-Initiative, who has gathered researchers with the common aim to develop COS 
for all conditions and treatments. Perthes’ Disease is an excellent example of why standardised 
outcome reporting is necessary, with the literature previously having 23 different outcome 
domains used to record “successful treatment” in Perthes’ disease. Nevertheless despite the 23 
different domains, there were domains of key importance to patients and families that had never 
previously been recorded, which only became evident from qualitative interviews. 
Furthermore, of the 23 domains in the literature, most studies would collect an assorted number 
of these domains without any consistency. Trying to synthesise useful information from these 
papers has therefore been difficult. The absence of clear outcomes is perhaps one of the main 
reasons for the wide diversity of treatments and opinions in the management of Perthes’ disease 
– where treatment is based more on surgeon preference than scientific evidence [8]. It is 
therefore unsurprising that the management of Perthes’ disease is one of the key research 
priorities in children’s orthopaedic surgery [18]. 
The COMET initiative developed guidelines and standards to help maintain the quality of the 
COS development process [10, 11, 17]. Across medicine there are a wide range of COSs for 
different conditions (e.g. paediatric asthma) [19], however the orthopaedic community has 
perhaps neglected the importance of these [20]; with COSs available for only a few orthopaedic 
conditions (e.g. hip fractures) [21].   
Our work has identified a list of core outcome domains to be measured and reported as a 
minimum in clinical research involving Perthes’ patients. Whilst this COS defines which 
outcome domains should be measured, it does not provide detail on how the outcomes should 
be measured; indeed, this may vary depending on the patient population or in response to 
advances in measurement tools. Some outcomes (e.g. femoral head shape) may already be 
routinely assessed as part of clinical practice [6], whereas other outcomes (e.g. sleep quality) 
are similarly important to families and require clinical and research teams to give consideration 
to how best to capture these outcomes. Likewise, outcomes such as hip mobility may be 
difficult to assess with an absence of objective instrumentations, so consideration also needs to 
be made as to how this can be achieved.  
Our work was conducted using well-established guidelines and a robust methodology. The 
established methodology (COMET-Initiative and OMERACT guidelines) and the inclusion of 
perspectives from clinicians, patients and their families, are clear strengths of our study. The 
Delphi approach has been recommended as an ideal approach to identify outcomes of interest 
in clinical research [11, 22], yet ten different ‘Delphi techniques’ are reported, and given this 
variation the rigour of the process has been questioned [23]. The drop-out in participants’ rate 
it is a well know problem of the Delphi technique [24], and this has affected also our study 
with a response rate of only 62% of the panel during round 2 of the survey. However, unlike 
studies following up clinical participants longitudinally, drop-outs in this type of study design 
are unlikely introduce bias [25]. A major strength of our work was to include qualitative 
interviews amongst affected children and families. We acknowledge that the participants for 
qualitative interviews were from a single UK centre that may not necessarily represent the view 
of patients worldwide. However, patient, parent and clinician involvement in the Delphi was 
truly international, and only 5 new outcomes suggested at this stage had not already been 
identified. The discussion and feedback obtained at the IPSG involved 20 international 
surgeons and their opinions were sought to get important feedback into the development of the 
COS. We acknowledge that the number of representatives attending the final consensus 
meeting was fewer than initially proposed [9], yet the representation was broad in terms of the 
locations and distribution of members within stakeholder groups, and the interim discussion 
within the IPSG generated key points of discussion from a key interest-group to bring to the 
final consensus meeting. We also acknowledge that the 14 outcomes proposed in the final COS 
are still a high number to be reported. Cochrane guidelines for systematic reviews suggest a 
maximum of 7 outcomes to be reported as this facilitate readers understanding and retrieval of 
the review [26]. However, most of the outcomes proposed (e.g. activity of daily living; sport 
participation; pain) may be collected using only few Patient-Reported Outcomes Measures 
(PROMs) tools, and therefore seems both acceptable to patients and achievable. 
In conclusion, our study followed defined guidelines and methodology to develop a COS for 
clinical research in Perthes’ disease. The adoption and acceptance of this COS in the paediatric 
orthopaedic community will help clarify the optimal treatment for Perthes’ disease. Future 
work is required to clearly define the optimal outcome tools to record these outcomes, though 
we hope that this will be the catalyst to develop further clinical research amongst children with 





This work is funded by the Liverpool John Moores University and Alder Hey Children’s 
Hospital. Additional support has come from the Perthes’ Association UK.  
 
ETHICS AND DISSEMINATION 
Consultation with the Health Research Authority deemed this study a service evaluation project 
with no requirement for ethical approval (reference 60/89/81). 
 
CONFLICT OF INTEREST 
None of the authors has any competing interests. Any competing interests relating to any 





The following people contributed to the TOP Consensus Meeting: Lisa Grant, CEO Perthes 
Association UK (Guildford, UK); Colleen Rathgeber, MBA, Founder of the Legg-Calve-
Perthes Foundation (Virginia, USA); Jamie Kirkham, PhD, Senior Lecturer in Medical 
Statistics, University of Liverpool (Liverpool, UK); Alexander Aarvold, MBChB, 
FRCSEd(Tr&Orth), Consultant Paediatric Orthopaedic Surgeon, Southampton Children's 
Hospital (Southampton, UK); Adam Galloway, MSc, Senior Children’s Physiotherapist, 
Leeds Children’s Hospital (Leeds, UK). 
The authors want also to thank the members of the International Perthes Study Group 
(IPSG) and the Perthes Association UK for their support and contribution to this study. 
 
AUTHORS´ CONTRIBUTIONS 
DCP, HJ and DGL conceived the study, and participated in its design. TG and AL designed 
the children questionnaire. TG, AL and RM designed the semi-structured interview´s 
questions. DGL and WYL did the systematic review of the literature. DGL completed the semi-
structured interviews with parents and the children booklet with the children. DGL, RM, TG 
and AL contributed to the design and analysis of the qualitative component. JL lead the 
discussion of the Delphi Survey at the IPSG. DCP, HJ, DGL and JL designed and conducted 
the final consensus meeting. DGL wrote the first draft of the manuscript. All authors edited the 




1. Perry D, Bruce C. Hip disorders in childhood. Surgery. 2011;29(4):24-9. 
2. Perry D, Bruce C, Pope D, Dangerfield P, Platt M, Hall A. Legg-Calvé-Perthes 
 disease in the UK: geographic and temporal trends in incidence reflecting differences 
 in degree of deprivation in childhood. Arthritis Rheum. 2012;64(5):1673-9. 
3. Perry D, Hall A. The epidemiology and Etiology of Perthes' disease. Orthop 
 Clin of N Am. 2011;42(3):5. 
4. Perry D, Machin D, Pope D, Bruce C, Dangerfield P, Platt M, et al. Racial and 
 geographic factors in the incidence of Legg-Calvé-Perthes' disease: a systematic 
 review. Am J Epid. 2012;175(3):159–66. 
5. Wiig O. Perthes' disease in Norway: A prospective study on 425 patients. Acta 
 Orthop Suppl. 2009;80(333):1-45. 
6. Moghadam M, Moradi A, Omidi-Kashani F. Clinical outcome of femoral 
 osteotomy  in patients with Legg-Calve-Perthes’ disease. Arch Bone Jt Surg. 
 2013;1(2):90-3. 
7. Onishi E, Ikeda N, Ueo T. Degenerative osteoarthritis after Perthes' disease: a  
 36-years follow-up. Arch Orthop Trauma Surg. 2011;131(5):701-7. 
8. Hefti F, Clarke N. The management of Legg-Calve-Perthes' disease: is there a 
 consensus? J Child Orthop. 2007;1(1):19-25. 
9. Leo DG, Leong WY, Gambling T, Long A, Murphy R, Jones H, et al. The 
 outcomes of  Perthes' disease of the hip: a study protocol for the development of a 
 core outcome set.  Trials. 2018 Jul 13;19(1):374. Epub 2018/07/15. 
10. COMET-Initiative. COMET Initiative. 2018 [06/2018]; Available from: 
 www.comet-initiative.org/. 
11. Boers M, Kirwan JR, Wells G, Beaton D, Gossec L, d'Agostino MA, et al. 
 Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0. J 
 Clinic  Epid. 2014 Jul;67(7):745-53. Epub 2014/03/04. 
12. Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and 
 mobile app for systematic reviews. System Rev. 2016 Dec 5;5(1):210. Epub 
 2016/12/07. 
13. Dorman SL, Shelton JA, Stevenson RA, Linkman K, Kirkham J, Perry DC. 
 Management of medial humeral epicondyle fractures in children: a structured review 
 protocol for a systematic review of the literature and identification of a core outcome 
 set using a Delphi survey. Trials. 2018 Feb 20;19(1):119. Epub 2018/02/21. 
14. Leo DG, Murphy R, Gambling T, Long A, Jones H, Perry DC. Perspectives on the 
 Social, Physical and Emotional Impact of Living with Perthes’ Disease in Children 
 and their Family: a Mixed Methods Study. Glob Pediatr Health. 2019;6:1-10. 
15. Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, et al. 
 GRADE guidelines: 3. Rating the quality of evidence. J Clinical Epid. 2011 
 Apr;64(4):401-6.  Epub 2011/01/07. 
16. VoxVote. VoxVote - Free Mobile Voting. 2019 [updated January 2019]; Available 
 from: https://www.voxvote.com/. 
17. Singh JA, Dohm M, Choong PF. Consensus on draft OMERACT core domains for 
 clinical trials of Total Joint Replacement outcome by orthopaedic surgeons: a report 
 from the International consensus on outcome measures in TJR trials (I-COMiTT) 
 group. BMC Musc Dis. 2017 2017/01/26;18(1):45. 
18. Metcalfe D, Peterson N, Wilkinson JM, Perry DC. Temporal trends and 
 survivorship  of total hip arthroplasty in very young patients: a study using the 
 National Joint Registry  data set. Bone Joint J. 2018 Oct;100-b(10):1320-9. 
 Epub 2018/10/09. 
19. Sinha IP, Gallagher R, Williamson PR, Smyth RL. Development of a core 
 outcome set for clinical trials in childhood asthma: a survey of clinicians,  parents, 
 and young people. Trials. 2012;13:103-. 
20. Ollivere BJ, Marson BA, Haddad FS. Getting the right answer: core outcome sets in 
 orthopaedics. Bone Joint J. 2019 Mar;101-b(3):233-5. Epub 2019/03/01. 
21. Haywood KL, Griffin XL, Archten J, Costa ML. Developing a core outcome set for 
 hip fracture trials. Bone Joint J. 2014;96-B(8):1016-23. 
22. Sinha IP, Smyth RL, Williamson PR. Using the Delphi technique to determine 
 which  outcomes to measure in clinical trials: recommendations for the future based 
 on a systematic review of existing studies. PLoS Med. 2011;8(1):e1000393-e. 
23. Keeney S, Hasson F, McKenna HP. A critical review of the Delphi technique as a 
 research methodology for nursing. Int J Nurs Stud. 2001 2001/04/01/;38(2):195-200. 
24. Hung H.-L., Altschuld JW, Lee Y.-F. Methodological and conceptual issues 
confronting a cross-country Delphi study of educational program evaluation. Eval 
program plann, 2008. 31(2): p. 191-198. 
25. Mullen PM. Delphi: myths and reality. J Health Organ Manag, 2003. 17(1): p. 37-52. 
26. Julian P. and Higgins T. Cochrane Handbook for Systematic Reviews of 






Table 1: Systematic review outcomes categorised in domains (OMERACT modified filter). 
Core Area Core Domains Outcomes 
Adverse events Adverse Events Deformity 
Life impact Physical/Social/Emotional/ 
Cognitive/Health Related 
Quality of Life 
Pain; activity of daily living; 
walking distance; use of 
walking aids; sit comfortably; 
pick up objects from the floor; 
climb stairs  
Table 2: PROs reported by the patients and parents interviews. 
 





Musculoskeletal Trendelenburg sign; gait 
analysis; uneven legs length; 
muscle strength; hip mobility 
Death N/A N/A 
Technical considerations Technical/Surgical 
considerations 
Acetabular coverage; acetabular 
shape; articulo-trochanteric 
distance; broken Shenton’s line; 
cartilaginous radii; evidence of 
arthritic changes; femoral head 
shape; neck shaft angle; 
overgrowth of great trochanter; 
stage of the disease 
Core Area Core Domains Outcomes 
Adverse events Adverse Events Complications of treatment 
Life impact Physical/Social/Emotional/ 
Cognitive/Health Related 
Quality of Life 
Limping, family finance; 
quality of life; school/pre-
school attendance; sleep 










Table 4: list of the outcomes that obtained “consensus in” after round 2 of the Delphi. 
 
Resource use Economic/Hospital/Need 
for intervention/Social 
burden 
Length of hospital stay; 
requirement for further 
surgery; skin problems  
Core Area Core Domains Outcomes 
Life impact Physical/Social/Emotional/ 
Cognitive/Health Related 
Quality of Life 
Family Life; Psychological 
Impact; weight gain 
Technical considerations Technical/Surgical 
considerations 
Time of re-ossification; hip 
congruency 
Core Area Core Domains Outcomes 
Adverse events Adverse Events Deformity; complications of 
treatment 
Life impact Physical/Social/Emotional/ 
Cognitive/Health Related 
Quality of Life 
Pain; activity of daily living; sit 
comfortably; quality of life; 







Table 5: The Defintive Core Outcome Set 
psychological impact; school 
attendance; sleep quality; 
walking distance 
 







Death N/A N/A 
Technical considerations Technical/Surgical 
considerations 
Acetabular coverage; evidence 
of arthritic changes; femoral 
head shape; hip congruency 
Core Area Core Domains Outcomes 
Adverse events Adverse Events complications of treatment  
Life impact Physical/Social/Emotional/ 
Cognitive/Health Related 
Quality of Life 
Pain; activity of daily living; 




sleep quality; sport 
participation 
 
Resource use Economic/Hospital/Need 
for intervention/Social 
burden 
requirement for further surgery 
Pathophysiological 
manifestations 
Musculoskeletal Hip mobility 
Death N/A N/A 
Technical considerations Technical/Surgical 
considerations 
Acetabular coverage and hip 
congruency; evidence of 
arthritic changes; femoral head 
shape  
